TGFBI and mesenchymal cell neoplasm: Previous studies have shown that Betaig-h3 gene is significantly reduced in embryonal rhabdomyosarcoma cell lines and mesenchymal tumours (Genini et al, 1996; Schenker and Trueb, 1998), suggesting that Betaig-h3 may have an important role in human cancer.